Enron Mail

From: brown_mary_jo@lilly.com To: alfred.gilman@email.swmed.edu, george.fisher@kodak.com,jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, kenneth.lay@enron.com, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu, win.bischoff@ssmb.com Subject: **PRESS RELEASE**SLIL Biomedical Announces Deal with Elanco Animal Cc: Bcc: Date: Thu, 12 Oct 2000 02:10:00 -0700 (PDT) Cc: brown_mary_jo@lilly.com Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Bcc: brown_mary_jo@lilly.com X-From: BROWN_MARY_JO@LILLY.COM X-To: alfred.gilman@email.swmed.edu, george.fisher@kodak.com, jterzuoli@ibjwhitehall.com, karen.n.horn@marsh.com, kenneth.lay@enron.com, kseifert@kcc.com, prendergast@mayo.edu, scb@purdue.edu, win.bischoff@ssmb.com X-cc: BROWN_MARY_JO@LILLY.COM X-bcc: X-Folder: \Kenneth_Lay_Dec2000\Notes Folders\Discussion threads X-Origin: LAY-K X-FileName: klay.nsf This press release was issued yesterday by SLIL Biomedical Corp. (See attached file: SLIL-Elanco Agreement.doc) COLLEEN PARKER Corporate Communications 276-3402 - SLIL-Elanco Agreement.doc